Search

Author/Creator Larsen, Annette K

1. Bevacizumab with or without erlotinib as maintenance therapy in patients with metastatic colorectal cancer (GERCOR DREAM; OPTIMOX3): a randomised, open-label, phase 3 trial. Issue 15 (November 2015)

Authors:
Tournigand, Christophe; Chibaudel, Benoist; Samson, Benoit; Scheithauer, Werner; Vernerey, Dewi; Mésange, Paul; Lledo, Gérard; Viret, Frédéric; Ramée, Jean-François; Tubiana-Mathieu, Nicole; Dauba, Jérôme; Dupuis, Olivier; Rinaldi, Yves; Mabro, May; Aucoin, Nathalie; Latreille, Jean; Bonnetain, F...
Journal:
Lancet oncology
Issue:
Volume 16:Issue 15(2015)
Page Start:
1493
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. PEPCOL: a GERCOR randomized phase II study of nanoliposomal irinotecan PEP02 (MM‐398) or irinotecan with leucovorin/5‐fluorouracil as second‐line therapy in metastatic colorectal cancer. (24th January 2016)

Authors:
Chibaudel, Benoist; Maindrault‐Gœbel, Frédérique; Bachet, Jean‐Baptiste; Louvet, Christophe; Khalil, Ahmed; Dupuis, Olivier; Hammel, Pascal; Garcia, Marie‐Line; Bennamoun, Mostefa; Brusquant, David; Tournigand, Christophe; André, Thierry; Arbaud, Claire; Larsen, Annette K; Wang, Yi‐Wen; Yeh, C. G...
Journal:
Cancer medicine
Issue:
Volume 5:Number 4(2016:Apr.)
Page Start:
676
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search